Expertise in
13
conditions

Hiroyuki Shimada

Matsumoto, JP 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
13
conditions
Matsumoto, JP 

Overview

Hiroyuki Shimada practices practicing medicine in Matsumoto, Japan.

Mr. Shimada is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Dementia, Endophthalmitis, Muscle Atrophy, Vitrectomy, and Cataract Removal.

He is actively involved in clinical research, co-authoring 605 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Matsumoto, Japan
Other Locations
Hiratsuka, 2548502, Japan
Obu, Japan
Okazaki, Japan
Tokyo, Japan
Nagano, Japan
Japan
Toyota, Japan
Saitama, 3300854, Japan
Nagoya, Japan
Sumiyoshi, Japan
Shinjuku, 1608582, Japan
Shinjiku, Japan
Shinanomachi, 1608582, Japan
Osaka, Japan
Chiyoda, 1018309, Japan
Morioka, Japan
Asahi, Japan
Koganei, 1848588, Japan
Chiba, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Dominantly Inherited Alzheimer Network (DIAN)
Dominantly Inherited Alzheimer Network (DIAN)
Enrollment Status: Recruiting
Publish Date: July 20, 2026
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 27, 2026
Intervention Type: Drug
Study Drugs: E2814, Lecanemab
Study Phase: Phase 2/Phase 3
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 27, 2026
Intervention Type: Drug
Study Drugs: Gantenerumab, Solanezumab
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trial

605 Total Publications

The Japanese Translation Study of the Cognitive Reserve Index Questionnaire.
The Japanese Translation Study of the Cognitive Reserve Index Questionnaire.
Journal: Geriatrics & gerontology international
Published: June 01, 2026

Frequently Asked Questions about Hiroyuki Shimada

Is Hiroyuki Shimada a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Hiroyuki Shimada is classified as an Distinguished expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hiroyuki Shimada participate in research or clinical trials?

Yes. Hiroyuki Shimada has published 605 articles and abstracts on conditions like Dementia. You can view a list of Hiroyuki Shimada's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Shimada's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 50 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile